Back
Moderna

Moderna

MRNA

Loading Stocks

$123.82

$1.53 (-1.22%)

1D

1W

3M

1Y

5Y

ALL

Overview

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics.

Open

$122.64

Prior close

$121.48

Today's high

$125.02

Today's low

$120.11

52 Week high

$170.47

52 Week low

$62.55
News
3 Biotech Stocks to Buy in Case of Another Pandemic
Newsfeed image icon
Moderna (MRNA) Stock Rises 22% YTD: Time to Buy the Stock?
Newsfeed image icon
2 Growth Stocks Down 25% to Buy Right Now
Newsfeed image icon
Is Moderna Stock a Buy?
Newsfeed image icon
View disclosures

Start Your Investing Journey At MoneyLion

Access fully managed portfolios to help you invest towards your future, without the heavy lifting.

Market Data

Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.